Inhaled Iloprost (Ventavis): Efficacy, Safety, and Pharmacokinetics (PK) Confirmation Study
NCT01469169
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
27
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypertension, Pulmonary
Interventions
DRUG:
Iloprost (Ventavis inhaled, BAYQ6256)
Sponsor
Bayer